Table 2.

Analysis of plasma parameters of male Swiss mice treated with LP (protium liposome) and CPA (cyclophosphamide).

Parameters	Control (C)	CPA	LP	LP + CPA
Glucose (mg/dL)	229.25 ± 57.17	224.62 ± 44.51	185.12 ± 43.79	251.75 ± 53.54
AST (U/L)	154.87 ± 42.00	185.50 ± 150.00	182.25 ± 97.00	186.12 ± 181.00
ALP (U/L)	112.62 ± 25.39	100.12 ± 19.65	96.62 ± 18.57	76.87 ± 7.84 *
Creatinine (mg/dL)	3.18 ± 0.66	2.13 ± 1.03 *	1.31 ± 0.46 *	1.45 ± 0.50 *
Cholesterol (mg/dL)	85.87 ± 14.24	79.80 ± 17.72	102.88 ± 32.83	95.30 ± 25.04
Triglycerides (mg/dL)	145.25 ± 16.62	126.00 ± 3.84 *	128.12 ± 16.27	136.12 ± 5.41

Results are presented as mean ± standard deviation using ANOVA (two-way), followed by Tukey’s post-hoc test. For AST analysis, a Kruskal–Wallis test, followed by Dunn’s post-hoc test, was used, and values were expressed as median and total range. * p < 0.05 vs. C. (AST: aspartate aminotransferase; ALP: alkaline phosphatase); (n = 8).